LexDanaLexDanabeta
Inventor

David BARBIE

Inventor
US

Overview

3→
Patents
2023–2024
Patent span
Chemistry
Primary field (CPC C)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C12Qprimary
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
C12MApparatus for enzymology or microbiology13%
C12NMicroorganisms or enzymes13%
C12YEnzymes13%
A61KPreparations for medical, dental or toiletry purposes7%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations7%
C07KPeptides7%
PatentTitleYear
12,116,636Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture device202411,874,276STING levels as a biomarker for cancer immunotherapy202411,572,590Methods for evaluating tumor cell spheroids using 3D microfluidic cell culture device2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to DANA FARBER CANCER INST INC (3)· patent assignee history
2023–2024Based in US· patent location history
2024Patents assigned to BRIGHAM & WOMENS HOSPITAL INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
DANA FARBER CANCER INST INC32023–2024
BRIGHAM & WOMENS HOSPITAL INC12024
Locations
LocationPatentsSpan
US32023–2024